ProfileGDS4718 / 226944_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 75% 75% 75% 76% 71% 70% 73% 75% 79% 74% 70% 75% 72% 72% 72% 73% 72% 79% 70% 83% 72% 71% 71% 72% 71% 75% 76% 71% 74% 75% 70% 83% 78% 71% 80% 76% 76% 77% 70% 80% 73% 75% 94% 80% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]7.295175
GSM549102patient 115, normal, homogenized [OPG study]7.2595775
GSM549104patient 119, normal, homogenized [OPG study]7.3773475
GSM549108patient 138, normal, homogenized [OPG study]7.3423276
GSM549119patient 077, normal, homogenized [OPG study]6.9260771
GSM549133patient 032, cancer, homogenized [OPG study]6.8901270
GSM549139patient 042, cancer, homogenized [OPG study]7.132873
GSM549099patient 107, normal, homogenized [OPG study]7.2483975
GSM549109patient 139, normal, homogenized [OPG study]7.6904179
GSM549110patient 046, normal, homogenized [OPG study]7.2277874
GSM549114patient 063, normal, homogenized [OPG study]6.8903570
GSM549122patient 082, normal, homogenized [OPG study]7.2898675
GSM549134patient 033, cancer, homogenized [OPG study]7.0870872
GSM549136patient 036, cancer, homogenized [OPG study]7.1403872
GSM549140patient 044, cancer, homogenized [OPG study]7.10872
GSM549111patient 047, normal, homogenized [OPG study]7.1707373
GSM549113patient 057, normal, homogenized [OPG study]7.1133772
GSM549132patient 031, cancer, homogenized [OPG study]7.7952179
GSM549137patient 038, cancer, homogenized [OPG study]6.8955370
GSM549142patient 047, cancer, homogenized [OPG study]7.9358983
GSM549100patient 110, normal, homogenized [OPG study]7.0164972
GSM549107patient 135, normal, homogenized [OPG study]6.9709371
GSM549115patient 068, normal, homogenized [OPG study]6.9784671
GSM549116patient 072, normal, homogenized [OPG study]7.0818672
GSM549120patient 078, normal, homogenized [OPG study]6.9664971
GSM549131patient 030, cancer, homogenized [OPG study]7.4430475
GSM549118patient 074, normal, homogenized [OPG study]7.4276876
GSM549129patient 027, cancer, homogenized [OPG study]6.9948671
GSM549123patient 088, normal, homogenized [OPG study]7.2025774
GSM549124patient 006, cancer, homogenized [OPG study]7.2989775
GSM549126patient 015, cancer, homogenized [OPG study]6.8543470
GSM549128patient 025, cancer, homogenized [OPG study]8.3113783
GSM549103patient 117, normal, homogenized [OPG study]7.4743478
GSM549117patient 073, normal, homogenized [OPG study]6.9273971
GSM549138patient 041, cancer, homogenized [OPG study]7.8872780
GSM549141patient 045, cancer, homogenized [OPG study]7.5683776
GSM549130patient 028, cancer, homogenized [OPG study]7.3906276
GSM549101patient 111, normal, homogenized [OPG study]7.4601577
GSM549105patient 128, normal, homogenized [OPG study]6.8683970
GSM549106patient 134, normal, homogenized [OPG study]8.0098680
GSM549112patient 048, normal, homogenized [OPG study]7.1389173
GSM549125patient 011, cancer, homogenized [OPG study]7.315475
GSM549127patient 024, cancer, homogenized [OPG study]9.8940494
GSM549135patient 035, cancer, homogenized [OPG study]7.96780